Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interventional Study to Evaluate Treating to a Target of Transmural Healing in Patients With Moderately to Severely Active Crohn's Disease

NCT06257706 is registered in ClinicalTrials.gov with Alimentiv Inc. as lead sponsor.

NCT NCT06257706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06257706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interventional Study to Evaluate Treating to a Target of Transmural Healing in Patients With Moderately to Severely Active Crohn's Disease
Lead sponsor
Alimentiv Inc.
Phase
Phase 4
Overall status
Recruiting
Start date
August 7, 2024
Completion date
February 6, 2029
Enrollment
304 (estimated)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, disease crohn, moderately to severely active crohn's disease